AU Patent

AU2012205214B2 — Formulation for Amine Polymers

Assigned to Genzyme Corp · Expires 2015-05-21 · 11y expired

What this patent protects

C:\NRPonbhN)CC\RBR\4477647_1.DOC-I$AI7/2M 2 A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the 5 anionic stabilizer. The powder formulation is conveniently pac…

USPTO Abstract

C:\NRPonbhN)CC\RBR\4477647_1.DOC-I$AI7/2M 2 A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the 5 anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012205214B2
Jurisdiction
AU
Classification
—
Expires
2015-05-21
Drug substance claim
No
Drug product claim
No
Assignee
Genzyme Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.